---
title: "Takeda nets first-in-class advantage on narcolepsy drug’s FDA go-ahead"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295117197.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-08-06T13:11:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295117197.md)
  - [en](https://longbridge.com/en/news/295117197.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295117197.md)
generator: "portal-rs"
---

# Takeda nets first-in-class advantage on narcolepsy drug’s FDA go-ahead

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [TAK.US](https://longbridge.com/en/quote/TAK.US.md)
- [4502.JP](https://longbridge.com/en/quote/4502.JP.md)

## Related News & Research

- [Takeda CHRO Nicola D. Greenway sells 12,980 ADS for $235,173.42](https://longbridge.com/en/news/296395853.md)
- [Takeda Pharmaceutical (NYSE:TAK) General Counsel Natalie Anne Marie Furney Sells 30,868 Shares of Stock](https://longbridge.com/en/news/295785108.md)
- [Takeda Pharmaceutical Insiders Sold Shares Worth Over $3.5M](https://longbridge.com/en/news/295731657.md)
- [Elaine Mary Shannon Sells 3,978 Shares of Takeda Pharmaceutical (NYSE:TAK) Stock](https://longbridge.com/en/news/295737078.md)
- [Forget Chips: These 3 Stocks Are Building the AI Data Center Boom](https://longbridge.com/en/news/296517157.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**